Diet Pills Market is expected to reach US$ 2,270.94 million by 2028

Prescription Segment to Dominate Product Type Segment of Diet Pills Market

According to our new research study on "Diet Pills Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product Type, Application, Age Group, and Distribution Channel," the market is expected to grow from US$ 1,132.55 million in 2021 to US$ 2,270.94 million by 2028; it is estimated to grow at a CAGR of 10.4% from 2021 to 2028. The increase in self-care, the rising problem of obesity, an increase in the elderly population, and a surge in women taking dietary supplements are driving the diet pills market. However, the challenging regulatory environment is expected to restrict the market growth during the forecast period.

The companies engaged in the diet pills market witnessed an adverse impact on their services in early 2020 due to the temporary shutdown of their laboratories. However, research laboratories reopened globally after the upliftment of lockdown. As a result, many service providers prioritized a few critical actions of the consumers during the COVID-19 pandemic, such as giving a range of high-quality COVID-19 related research tools; reassigning R&D resources for producing essential products; expanding the supply chain; supporting increased demand for COVID-19-related research products; and entering into discussions and collaborations across the UK, the US, and China concentrated on SARS-CoV-2 diagnostics, drugs, and vaccines development. Moreover, sales of dietary supplements for immune health increased after the emergence of the COVID-19 outbreak. Many people hoped that these products might protect consumers against SARS-CoV-2 infection and reduce disease severity in COVID-19 patients. Moreover, after establishing COVID-19 vaccines, the diet pills market is expected to have positive growth in the coming years.

The product types in the diet pills market are segmented into prescription, over the counter drugs, and herbal supplements. The prescription segment is expected to hold a significant market share during the forecast period. However, the herbal supplements segment is expected to have the highest CAGR. Prescription diet pills can help obese people lose weight. Diet pills are prescribed by a doctor when a proper diet and physical exercises are also not working. Each of these medicines works differently. People who consume these medicines may not feel as hungry after eating only a small amount of food. Diet pills also make it harder for the body to absorb fat. Prescription diet pills can be helpful when combined with a low-calorie diet and regular physical activity. Diet pills, one of the easiest and most effective weight loss methods of this period, have dominated the market scenario for the past few years. New and upgraded versions of these pills are introduced to keep this industry growing. Prescription diet pills approved for long-term use (more than 12 weeks) produce significant weight loss compared to placebo.

Novo Nordisk A/S, Gelesis, VIVUS LLC, Chong's Health Care, GlaxoSmithKline plc., Pfizer Inc. (Arena Pharmaceutical GmbH), Iovate Health Sciences International Inc., Zoller Laboratories, Currax Pharmaceuticals LLC., TEVA PHARMACEUTICAL INDUSTRIES LTD. are among the key companies operating in the diet pills market.

Diet Pills Market, by Geography, 2021 (%)

---

Diet Pills Market Size & Trends | Forecast 2021, 2028

Download Free Sample

---

Diet Pills Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Prescription, Over the Counter Drugs and Herbal Supplements), Application (Appetite Suppression, Fat Blocking, Metabolism Raising Pills, and Others), Age Group (Teenagers and Adults), and Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies & Drug Stores)

The report segments the Diet Pills market as follows: